Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease

Stem Cell Research & Therapy

Tim Ahfeldt¹  Elena Coccia¹ 

[1] Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, US;Department of Neurology, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, US;Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, US;Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, US;Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, US;

关键词: Neurodegenerative disease modeling;    Human pluripotent stem cells (hPSCs);    CRISPR;    Parkinson’s disease;    GBA;   

DOI  :  10.1186/s13287-021-02326-5

来源: Springer

【 摘 要 】

The derivation of human embryonic stem cells followed by the discovery of induced pluripotent stem cells and leaps in genome editing approaches have continuously fueled enthusiasm for the development of new models of neurodegenerative diseases such as Parkinson’s disease (PD). PD is characterized by the relative selective loss of dopaminergic neurons (DNs) in specific areas of substantia nigra pars compacta (SNpc). While degeneration in late stages can be widespread, there is stereotypic early degeneration of these uniquely vulnerable neurons. Various causes of selective vulnerability have been investigated but much remains unclear. Most studies have sought to identify cell autonomous properties of the most vulnerable neurons. However, recent findings from genetic studies and model systems have added to our understanding of non-cell autonomous contributions including regional-specific neuro-immune interactions with astrocytes, resident or damage-activated microglia, neuro-glia cell metabolic interactions, involvement of endothelial cells, and damage to the vascular system. All of these contribute to specific vulnerability and, along with aging and environmental factors, might be integrated in a complex stressor-threshold model of neurodegeneration. In this forward-looking review, we synthesize recent advances in the field of PD modeling using human pluripotent stem cells, with an emphasis on organoid and complex co-culture models of the nigrostriatal niche, with emerging CRISPR applications to edit or perturb expression of causal PD genes and associated risk factors, such as GBA, to understand the impact of these genes on relevant phenotypes.

【 授权许可】

CC BY